Horizon Wealth Management, LLC Eli Lilly & CO Transaction History

Horizon Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	BUY	$592.2 - $792.28 $169,961 - $227,384	287 New	287 $223,000
Q2 2022 Aug 02, 2022	BUY	$278.73 - $327.27 $39,022 - $45,817	140 Added 9.2%	1,662 $539,000
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $938 - $1,166	4 Added 0.26%	1,522 $436,000
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $341,322 - $423,582	1,518 New	1,518 $419,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Horizon Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Horizon Wealth Management, LLC with notifications on news.